Published online Mar 28, 2015. doi: 10.5320/wjr.v5.i1.17
Peer-review started: September 28, 2014
First decision: November 19, 2014
Revised: December 10, 2014
Accepted: December 29, 2014
Article in press: January 4, 2015
Published online: March 28, 2015
Processing time: 176 Days and 5.9 Hours
The prevalence and severity of obstructive sleep apnea (OSA) is higher in specific population: children, elderly, obese and patients with pulmonary and cardiovascular diseases, compared to the general population. OSA is associated with greater morbidity and mortality in these patients. Although full-night polysomnography is still the gold standard diagnostic sleep study for OSA, it is a time consuming, expensive and technically demanding exam. Over the last few years, there is growing evidence on the use of portable monitors (PM) as an alternative for the diagnosis of OSA. These devices were developed specially for sleep evaluation at home, at a familiar environment, with easy self-application of monitoring, unattended. The use of PM is stablished for populations with high pre-test probability of OSA. However, there is a lack of studies on the use of PM in age extremes and patients with comorbidities. The purpose of this review is to present the studies that evaluated the use of PM in specific population, as well as to describe the advantages, limitations and applications of these devices in this particular group of patients. Although the total loss rate of recordings is variable in different studies, the agreement with full-night polysomnography justifies the use of PM in this population.
Core tip: This is the first review that evaluated the use of Portable Monitoring as an alternative method for diagnosis of obstructive sleep apnea in specific population. Additionally, we present the physiopathological background, technical considerations and clinical implications on the use of PM in age extremes and patients with comorbidites. We also describe the advantages, limitations and applications of these devices in children, elderly, patients with cardiovascular or respiratory diseases and obese patients.